Top Stories

The U.S. Food and Drug Administration released a Drug Safety Communication on July 20, 2021, concerning the removal of the strongest warning against using statins during pregnancy. The warning states that statins should never be used in any patients during pregnancy. After reviewing recent... more

Section:

0
No votes yet

Further results from the two phase 3 trials of the omega-3 fatty acid product ethyl eicosapentaenoic acid (EPA) (AMR101, Amarin), which showed the agent reduced triglycerides without increasing low-density lipoprotein (LDL) and reduced the number of atherogenic particles, were presented last week... more

Section:

0
No votes yet

Amit Khera, M.D., Saskia Neher, Ph.D., each earn two-year grant for lipid disorder research NLA Junior Faculty Research Award Information JACKSONVILLE, Fla. — The National Lipid Association (NLA) announced on Thursday the recipients of its inaugural Junior Faculty Research Awards for... more

Section:

0
No votes yet

Novartis announced that the U.S. Food and Drug Administration (FDA) approved Leqvio (inclisiran) as an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with clinical atherosclerotic cardiovascular disease (ASCVD) or heterozygous familial hypercholesterolemia (HeFH... more

Section:

0
No votes yet

When Kennedi Thompson started developing xanthomas – fatty deposits that appear as white, raised bumps on the skin – her parents initially thought she was having an allergic reaction. Fox News - January 18, 2012

Section:

0
No votes yet

In >95% of patients, high triglycerides reflect the burden of the effects of more than 30 genes involved in triglyceride pathways Published in Lancet Diabetes & Endocrinology,1 Free to download from 31 January – 28 February 2014 at http://www.thelancet.com/journals/landia/article/... more

Section:

0
No votes yet

Jacksonville, Florida - (August 25, 2022) - The American College of Cardiology (ACC) announced the release of the 2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of... more

Section:

0
No votes yet

Heart disease is the biggest killer in the country. But an argument is raging about a popular way of preventing it.   Wall Street Journal - January 23, 2012

Section:

0
No votes yet

From Washington Post: The ubiquitous nutrition label on food packages is about to get its first overhaul in 20 years, a change that is likely to have a dramatic effect on what people choose to eat and drink and what products sell on supermarket shelves. Obama administration officials say the... more

Section:

0
No votes yet

JACKSONVILLE, Fla. -- The National Lipid Association announced Monday it has united with MD Magazine®, a leading online and print source of physician news, conference coverage, and peer-to-peer discussion, through Michael J. Hennessy Associates' Strategic Alliance Partnership (SAP) Program... more

Section:

0
No votes yet